Community-associated methicillin-resistant Staphylococcus aureus, Switzerland.
Two case-control studies evaluated the prevalence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) carriage at hospital admission and characteristics of patients with CA-MRSA. Among 14,253 patients, CA-MRSA prevalence was 0.9/1,000 admissions. Although 5 CA-MRSA isolates contained Panton-Valentine leukocidin, only 1 patient had a previous skin infection. No easily modifiable risk factor for CA-MRSA was identified.
Harbarth
Stephan
S
University of Geneva Hospitals, Geneva, Switzerland. stephan.harbarth@hcuge.ch
François
Patrice
P
Shrenzel
Jacques
J
Fankhauser-Rodriguez
Carolina
C
Hugonnet
Stephane
S
Koessler
Thibaud
T
Huyghe
Antoine
A
Pittet
Didier
D
D000328:Adult; D000368:Aged; D002353:Carrier State / Q000453:epidemiology* / Q000382:microbiology; D016022:Case-Control Studies; D017714:Community-Acquired Infections / Q000453:epidemiology* / Q000382:microbiology; D005260:Female; D006801:Humans; D008297:Male; D016106:Methicillin Resistance; D008875:Middle Aged; D010343:Patient Admission / Q000706:statistics & numerical data; D015995:Prevalence; D013203:Staphylococcal Infections / Q000453:epidemiology* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects*; D013557:Switzerland / Q000453:epidemiology